Professional Documents
Culture Documents
Veterinary Microbiology
journal homepage: www.elsevier.com/locate/vetmic
Department of Veterinary Science, University of Parma, Via del Taglio, 10 - 43126 Parma, Italy
Istituto Zooprolattico Sperimentale della Lombardia e dellEmilia Romagna B. Ubertini Sezione diagnostica di Bologna, Via Ficorini,
5 - 40127 Bologna, Italy
A R T I C L E I N F O
A B S T R A C T
Article history:
Received 27 August 2013
Received in revised form 11 November 2013
Accepted 15 November 2013
The systemic and respiratory local immune response induced by the intradermal
administration of a commercial inactivated Mycoplasma hyopneumoniae whole-cell
vaccine (Porcilis1 MHYO ID ONCE MSD AH) in comparison with two commercial
vaccines administered via the intramuscular route and a negative control (adjuvant only)
was investigated. Forty conventional M. hyopneumoniae-free pigs were randomly assigned
to four groups (ten animals each): Group A = intradermal administration of the test vaccine
by using the needle-less IDAL1 vaccinator at a dose of 0.2 ml; Group B = intramuscular
administration of a commercially available vaccine (vaccine B); Group C = intramuscular
administration of the adjuvant only (2 ml of X-solve adjuvant); Group D = intramuscular
administration of a commercially available vaccine (vaccine D). Pigs were vaccinated at 28
days of age. Blood and bronchoalveolar lavage (BAL) uid samples were collected at
vaccination (blood only), 4 and 8 weeks post-vaccination. Serum and BAL uid were tested
for the presence of antibodies by ELISA test. Peripheral blood monomorphonuclear cells
(PBMC) were isolated to quantify the number of IFN-g secreting cells by ELISpot.
Moreover, cytokine gene expression from the BAL uid was performed. Total antibodies
against M. hyopneumoniae and specic IgG were detected in serum of intradermally and
intramuscularly (vaccine B only) vaccinated pigs at 4 and 8 weeks post-vaccination. M.
hyopneumoniae specic IgA were detected in BAL uid from vaccinated animals (Groups A
and B) but not from controls and animals vaccinated with the bacterin D (p < 0.05).
Signicantly higher gene expression of IL-10 was observed in the BAL uid at week 8 postvaccination in the intradermally vaccinated pigs (p < 0.05). The results support that the
intradermal administration of an adjuvanted bacterin induces both systemic and mucosal
immune responses. Moreover, the intramuscularly administered commercial vaccines
each had a different ability to stimulate the immune response both systemically and
locally.
2013 Elsevier B.V. All rights reserved.
Keywords:
Pig
M. hyopneumoniae
Vaccination
Intradermal
1. Introduction
* Corresponding author. Tel.: +39 0521 032698; fax: +39 0521 032692.
E-mail address: paolo.martelli@unipr.it (P. Martelli).
0378-1135/$ see front matter 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.vetmic.2013.11.025
358
to
359
Table 1
Details of the primer sequences of swine pro-inammatory (TNF-a, IL-6) and immune (IFN-g, IL-10) cytokines used for quantitative SYBR Green real-time
PCR amplication. The GAPDH gene was used as endogenous control gene.
Slope
r2
Amplied
product (bp)
98.5
3.36
0.99
118
for 50 -GGCAAAAGGGAAAGAATCCAG-30
rev 50 -CGTTCTGTGACTGCAGCTTATCC-30
95.9
3.43
0.99
87
NM_213948
for 50 -TGGTAGCTCTGGGAAACTGAATG-30
rev 50 -GGCTTTGCGCTGGATCTG-30
99.7
3.32
0.99
79
IL-10
(Royaee et al., 2004)
NM_214041
for 50 -TGAGAACAGCTGCATCCACTTC-30
rev 50 -TCTGGTCCTTCGTTTGAAAGAAA-30
106.7
3.17
0.98
114
GAPDH
(Primer Express)
NM_001206359
for 50 -GGTGAAGGTCGGAGTGAACG-30
rev 50 -GCCAGAGTTAAAAGCAGCCCT-30
100.3
3.32
0.99
70
Target gene
GenBank accession
number
Primer sequence
NM_214022
for 50 -ACTGCACTTCGAGGTTATCGG-30
rev 50 -GGCGACGGGCTTATCTGA-30
IL-6
(Meissonnier et al., 2008)
NM_214399
IFN-g
(Royaee et
TNF-a
(Meissonnier et
al., 2008)
al., 2004)
qPCR
efciency (%)
360
361
Table 2
Results of ELISA serology against Mycoplasma hyopneumoniae at vaccination (0), 4 and 8 weeks post-vaccination (PV). Values are expressed as average
OD SD at 450 nm (values with different letters within a column are signicantly different; p < 0.05).
Group
4 weeks PV
8 weeks PV
0/10
1.47 0.47a
10/10
3.673 0.67a
10/10
3.88 0.88a
0/10
1.3 0.3a
10/10
4.0 0.4a
10/10
4.53 0.53a
0/10
1.58 0.58a
0/10
1.93 0.3b
0/10
1.61 0.61b
0/10
1.41 0.41a
0/10
1.44 0.44b
0/10
1.27 0.27b
Table 3
Mycoplasma hyopneumoniae-specic IgG antibody response (mean SD of the OD670nm) in the serum at vaccination (0), 4 and 8 weeks post-vaccination (PV)
(values with different letters within a column are signicantly different; p < 0.05).
0
4 weeks PV
8 weeks PV
Group
Number of seropositive overall pigs
Average OD SD
0/10
0.34 0.04
6/10
0.97 0.09a
6/10
1.29 0.70a
0/10
0.23 0.02
7/10
0.98 0.08a
6/10
1.40 0.03a
0/10
0.33 0.03
0/10
0.44 0.09b
0/10
0.57 0.09b
0/10
0.35 0.03
0/10
0.67 0.12b
0/10
0.65 0.08b
4. Discussion
Table 4
Mycoplasma hyopneumoniae IgA antibody (mean SD of OD values at 450 nm) in BAL uid at 4 and 8 weeks post-vaccination (PV) (values with different letters
within a column are signicantly different; p < 0.05).
Group
4 weeks PV
8 weeks PV
nt
nt
6/10
0.45 0.05a
6/10
0.63 0.03a
nt
nt
6/10
0.53 0.03b
8/10
0.66 0.01a
nt
nt
0/10
0.36 0.04a
0/10
0.34 0.05b
nt
nt
0/10
0.36 0.04a
0/10
0.40 0.04b
362
Fig. 1. Post-vaccination gene expression levels of TNF-a, IL-6, IFN-g and IL-10 in the BAL uid of vaccinated (A, B and D groups) and non-vaccinated control
(C) pigs. Data are reported as relative (RQ: relative quantication) values normalized to GAPDH gene expression levels (mean values standard deviation).
The asterisk refers to statistically signicant differences between groups; p < 0.05.
Fig. 2. Post-vaccination frequencies of Mycoplasma hyopneumoniaespecic IFN-g secreting cells in PBMC of vaccinated (A, B and D
Groups) and non-vaccinated control (C) pigs. Data are expressed as
number of IFN-g secreting cells (SC) per million of PBMC (IFN-g SC/106
PBMC) and each value represents the mean response standard deviation
(values with different letters are signicantly different between groups;
p < 0.05).
363
364
Thacker, E.L., Thacker, B.J., Kuhn, M., Hawkins, P.A., Waters, W.R., 2000.
Evaluation of local and systemic immune responses induced by
intramuscular injection of a Mycoplasma hyopneumoniae bacterin
to pigs. Am. J. Vet. Res. 61 (November (11)) 13841389.
Thacker, E.L., Thacker, B.J., Boettcher, T.B., Jayappa, H., 1998. Comparison
of antibody production, lymphocyte stimulation, and protection
induced by four commercial Mycoplasma hyopneumoniae bacterins.
Swine Health Prod. 6 (May (3)) 107112.
Villarreal, I., Maes, D., Vranckx, K., Calus, D., Pasmans, F., Haesebrouck, F.,
2011. Effect of vaccination of pigs against experimental infection with
high and low virulence Mycoplasma hyopneumoniae strains. Vaccine
29 (February (9)) 17311735.
Vranckx, K., Maes, D., Marchioro, S.B., Villarreal, I., Chiers, K., Pasmans, F.,
et al., 2012. Vaccination reduces macrophage inltration in bronchusassociated lymphoid tissue in pigs infected with a highly virulent
Mycoplasma hyopneumoniae strain. BMC Vet. Res. March, 8.